MED-PHARMEX Trademark

Trademark Overview

On Friday, July 20, 2012, a trademark application was filed for MED-PHARMEX with the United States Patent and Trademark Office. The USPTO has given the MED-PHARMEX trademark a serial number of 85682336. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, March 27, 2024. This trademark is owned by Med-Pharmex, Incorporated. The MED-PHARMEX trademark is filed in the Pharmaceutical Products category with the following description:

Animal health pharmaceutical preparations and products for use in treating [ appetite disorders, ] digestive disorders, dysentery, bacterial enteritis, respiratory diseases, [ excessive sweating, ] [ udder discomfort and abrasions, ] parasites, [ eye infections, ] fungal infections and bacterial skin disorders, ear infections, [ anal gland infections, ringworm, interdigital cysts, ] bacterial infections susceptible to tetracycline hydrochloride [, coccidiosis, fowl cholera, infectious coryza, shipping fever complex, bacterial pneumonia, calf diphtheria, foot rot, nutritional dietary deficiencies; injectible drugs for animals for purposes of euthanasia, anesthetics, and vitamin supplements ]
med-pharmex

General Information

Serial Number85682336
Word MarkMED-PHARMEX
Filing DateFriday, July 20, 2012
Status800 - REGISTERED AND RENEWED
Status DateWednesday, March 27, 2024
Registration Number4386721
Registration DateTuesday, August 20, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2013

Trademark Statements

Goods and ServicesAnimal health pharmaceutical preparations and products for use in treating [ appetite disorders, ] digestive disorders, dysentery, bacterial enteritis, respiratory diseases, [ excessive sweating, ] [ udder discomfort and abrasions, ] parasites, [ eye infections, ] fungal infections and bacterial skin disorders, ear infections, [ anal gland infections, ringworm, interdigital cysts, ] bacterial infections susceptible to tetracycline hydrochloride [, coccidiosis, fowl cholera, infectious coryza, shipping fever complex, bacterial pneumonia, calf diphtheria, foot rot, nutritional dietary deficiencies; injectible drugs for animals for purposes of euthanasia, anesthetics, and vitamin supplements ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 26, 2012
Primary Code005
First Use Anywhere DateWednesday, November 30, 2005
First Use In Commerce DateWednesday, November 30, 2005

Trademark Owner History

Party NameMed-Pharmex, Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPomona, CA 91767
Party NameMed-Pharmex, Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPomona, CA 91767
Party NameMed-Pharmex, Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPomona, CA 91767

Trademark Events

Event DateEvent Description
Thursday, November 15, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 24, 2012NEW APPLICATION ENTERED
Thursday, July 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 15, 2012ASSIGNED TO EXAMINER
Thursday, November 15, 2012NON-FINAL ACTION E-MAILED
Thursday, November 15, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 12, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 12, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 26, 2013ASSIGNED TO LIE
Friday, April 26, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 15, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2013PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, November 25, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 20, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 23, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 26, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 26, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, August 20, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 21, 2023TEAS SECTION 8 & 9 RECEIVED
Wednesday, September 6, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 7, 2023OFFICE ACTION ISSUED POU1
Thursday, March 7, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, March 18, 2024PROOF OF USE INTERIM ACTION ISSUED
Tuesday, March 19, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, March 27, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 27, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, June 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 27, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, June 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

pharmex infections bacterial disorders fever hydrochloride complex pneumonia calf coccidiosis shipping